Literature DB >> 23712246

Cardiovascular endocrinology: Risk of venous thromboembolism with glucocorticoids.

John A Heit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23712246     DOI： 10.1038/nrendo.2013.107

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer.

Authors:  Charles L Bennett; Cara Angelotta; Paul R Yarnold; Andrew M Evens; Jeffrey A Zonder; Dennis W Raisch; Paul Richardson
Journal:  JAMA       Date:  2006-12-06       Impact factor: 56.272

Review 2.  The epidemiology of venous thromboembolism in the community.

Authors:  John A Heit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

3.  Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study.

Authors:  Peter A Merkel; Grace H Lo; Janet T Holbrook; Andrea K Tibbs; Nancy B Allen; John C Davis; Gary S Hoffman; W Joseph McCune; E William St Clair; Ulrich Specks; Robert Spiera; Michelle Petri; John H Stone
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

4.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

5.  Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events.

Authors:  Vanesa Caruso; Augusto Di Castelnuovo; Susana Meschengieser; Maria A Lazzari; Giovanni de Gaetano; Sergio Storti; Licia Iacoviello; Maria Benedetta Donati
Journal:  Blood       Date:  2010-04-08       Impact factor: 22.113

6.  Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.

Authors:  Sigrun A Johannesdottir; Erzsébet Horváth-Puhó; Olaf M Dekkers; Suzanne C Cannegieter; Jens Otto L Jørgensen; Vera Ehrenstein; Jan P Vandenbroucke; Lars Pedersen; Henrik Toft Sørensen
Journal:  JAMA Intern Med       Date:  2013-05-13       Impact factor: 21.873

7.  Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution.

Authors:  Marianne Tang Severinsen; Søren Risom Kristensen; Kim Overvad; Claus Dethlefsen; Anne Tjønneland; Søren Paaske Johnsen
Journal:  J Clin Epidemiol       Date:  2010-02       Impact factor: 6.437

8.  Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study.

Authors:  J W Blom; J P M Vanderschoot; M J Oostindiër; S Osanto; F J M van der Meer; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2006-03       Impact factor: 5.824

Review 9.  Thrombosis and acute lymphoblastic leukaemia.

Authors:  Jeanette H Payne; Ajay J Vora
Journal:  Br J Haematol       Date:  2007-06-29       Impact factor: 6.998

10.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients.

Authors:  Sandra K Thygesen; Christian F Christiansen; Steffen Christensen; Timothy L Lash; Henrik T Sørensen
Journal:  BMC Med Res Methodol       Date:  2011-05-28       Impact factor: 4.615
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.